Air Pollution Linked to Autoimmune Diseases PDF Print E-mail
Sunday, 31 January 2010 12:53
taken from http://www.flickr.com/photos/ikhlasulamal/4224395355/ via creative commonsMany people with environmental illnesses have an assortment of autoimmune diseases which scientists are linking to air pollution.

Though genetic factors have been found for autoimmune diseases, this knowledge has not helped to prevent them. In fact, according to researcher Stacy Ritz of the Northern Ontario School of Medicine, autoimmune diseases are rising at a dramatic rate.

"Population-level genetic changes cannot explain this trend; thus, environmental factors are strongly implicated," says Ritz in a recently published study. "Among the possible environmental contributors to autoimmune disease, air pollution exposure has received very little attention. Although there is only a small amount of published data directly examining a possible causal relationship between air pollution exposure and autoimmunity, data from related fields suggests that it could facilitate autoimmunity as well."

Antonella Zanobetti, a senior research scientist at the Harvard School of Public Health found that particulate matter in air pollution from industrial combustion and traffic significantly increased hospital admissions for cardiac problems, respiratory disease, and diabetes.

There are over 80 autoimmune diseases. Some of the more common ones include type 1 Diabetes, certain Thyroid and Adrenal disorders, Multiple Sclerosis, Scleroderma, Rheumatoid arthritis, Lupus, and Sjogren's Syndrome.

Autoimmune diseases are characterized by an immune response which leads to the destruction of the body´s own organs and tissues. They are frequently endocrine system related. Essentially the body treats its organs and tissues as though they were a foreign invader and the immune system kicks in to kill off the invader.

Many chemical pollutants are known endocrine disruptors. Though dose specific exposures may be considered safe, little research has been done on the cumulative and synergistic effects of the many multiple and unavoidable exposures humans are subjected to each day.

On a daily basis, humans are exposed to a chemical cocktail of pesticides, herbicides, automobile exhaust, and industrial pollution. Often overlooked sources of exposure may also be found in the home in the form of cleaning solutions, fragranced products, air freshener chemicals, and chemicals used in the manufacture of furniture, carpet, plastics, and other household goods.

Log in to download a copy of MCSA's newsletter containing the full article, below.

Source: MCSA News (2010), "Air Pollution Linked to Autoimmune Diseases", Vol. 5, Issue 2, February

 
More articles :

» Cell Therapy Yields Promising Results For Scleroderma Treatment

Cytori Therapeutics, Inc. provided preliminary data from a study evaluating a potential treatment for Scleroderma based on the company's cell therapy. The investigator-funded, open-label, pilot study is being conducted on patients with Cutaneous...

» Scleroderma Study Results Comes As Bitter Disappointment

Elizabeth Lombard has .The disease, which has no cure, has long confounded South Boston, where a cluster of longtime residents from the City Point section - most of them middle-aged women - were falling ill with it. The residents, who lived near a...

» Interferons As A Potential Treatment For Scleroderma

A variety of new treatments are being currently investigated and developed for the treatment of Systemic in hopes of better controlling symptoms and slowing the progression of the disease. Once such treatment is Interferons, in which recent studies...

» Donating Kidney Doesn't Shorten Lifespan

A study of over 80,000 American live kidney donors found they were likely to live just as long as people who have two healthy kidneys and that the procedure carries very little medical risk.You can read about the by lead author and transplant...

» Liver Autoantibodies in Patients with Scleroderma

Thelma L. Skare & Renato M. Nisihara & Osvaldo Haider & Pedro M. Azevedo & Shirley R. R. UtiyamaClin RheumatolDOI 10.1007/s10067-010-1586-0Association between autoimmune liver diseases and scleroderma has been described. The purpose...

» Rituximab Shows Promise in Scleroderma

Rituximab (Rituxan) improved lung function in patients with , a small proof-of-principle study found.At one year, patients randomized to receive rituximab had a median 10.25% increase in forced vital capacity (FVC) compared with baseline, while...